Metropolitan Land Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Metropolitan Land Tbk. trades at Rp535 (market cap 4.13T, 32.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Metropolitan Land Tbk. is far larger — about 24.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 32.9K). Which is the better fit depends on your goals.
| MTLA | OBAT | |
|---|---|---|
Market Cap | 4.13T | 166.01B |
Volume | 32.9K | 324K |
Lot | 329 | 3.24K |
Turnover | 17.14M | 77.68M |
Average Price | 520.88 | 239.75 |
Value | 17.14M | 77.68M |
Indicative Equilibrium Price | 530 | 240 |
Indicative Equilibrium Volume | 53 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metropolitan Land Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amenden by Law No. 12 year 1970 based on notarial deed No. 37 dated February 16, 1994 of Endang Irawati Ekaputri, S.H., Notary in Jakarta.
Read more on MTLA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →